Papp Janos, Kovacs Marietta Eva, Matrai Zoltan, Orosz Enikő, Kásler Miklós, Børresen-Dale Anne-Lise, Olah Edith
Department of Molecular Genetics, National Institute of Oncology, Rath Gy. u. 7-9, Budapest, 1122, Hungary.
Hamon Center for Therapeutic Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Fam Cancer. 2016 Jan;15(1):85-97. doi: 10.1007/s10689-015-9845-5.
Familial adenomatous polyposis (FAP) is a colorectal cancer predisposition syndrome with considerable genetic and phenotypic heterogeneity, defined by the development of multiple adenomas throughout the colorectum. FAP is caused either by monoallelic mutations in the adenomatous polyposis coli gene APC, or by biallelic germline mutations of MUTYH, this latter usually presenting with milder phenotype. The aim of the present study was to characterize the genotype and phenotype of Hungarian FAP patients. Mutation screening of 87 unrelated probands from FAP families (21 of them presented as the attenuated variant of the disease, showing <100 polyps) was performed using DNA sequencing and multiplex ligation-dependent probe amplification. Twenty-four different pathogenic mutations in APC were identified in 65 patients (75 %), including nine cases (37.5 %) with large genomic alterations. Twelve of the point mutations were novel. In addition, APC-negative samples were also tested for MUTYH mutations and we were able to identify biallelic pathogenic mutations in 23 % of these cases (5/22). Correlations between the localization of APC mutations and the clinical manifestations of the disease were observed, cases with a mutation in the codon 1200-1400 region showing earlier age of disease onset (p < 0.003). There were only a few, but definitive dissimilarities between APC- and MUTYH-associated FAP in our cohort: the age at onset of polyposis was significantly delayed for biallelic MUTYH mutation carriers as compared to patients with an APC mutation. Our data represent the first comprehensive study delineating the mutation spectra of both APC and MUTYH in Hungarian FAP families, and underscore the overlap between the clinical characteristics of APC- and MUTYH-associated phenotypes, necessitating a more appropriate clinical characterization of FAP families.
家族性腺瘤性息肉病(FAP)是一种具有显著遗传和表型异质性的结直肠癌易感综合征,其定义为整个结直肠出现多个腺瘤。FAP由腺瘤性息肉病 coli 基因 APC 的单等位基因突变引起,或由 MUTYH 的双等位基因种系突变引起,后者通常表现出较轻的表型。本研究的目的是对匈牙利 FAP 患者的基因型和表型进行特征分析。使用 DNA 测序和多重连接依赖探针扩增技术,对来自 FAP 家族的 87 名无血缘关系的先证者(其中 21 例表现为疾病的减弱型,息肉少于 100 个)进行了突变筛查。在 65 名患者(75%)中鉴定出 24 种不同的 APC 致病突变,包括 9 例(37.5%)具有大片段基因组改变的病例。其中 12 个点突变是新发现的。此外,还对 APC 阴性样本进行了 MUTYH 突变检测,我们在这些病例的 23%(5/22)中鉴定出双等位基因致病突变。观察到 APC 突变的定位与疾病临床表现之间的相关性,密码子 1200 - 1400 区域发生突变的病例疾病发病年龄较早(p(p < 0.003)。在我们的队列中,APC 相关和 MUTYH 相关的 FAP 之间只有少数但明确的差异:与 APC 突变患者相比,双等位基因 MUTYH 突变携带者的息肉病发病年龄显著延迟。我们的数据代表了第一项全面研究匈牙利 FAP 家族中 APC 和 MUTYH 突变谱的研究,并强调了 APC 和 MUTYH 相关表型临床特征之间的重叠,这需要对 FAP 家族进行更合适的临床特征描述。